MASIMO CORP — Director's Dealing 2023

Aug 9, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Neuraxis, INC (NRXS)
CIK: 0001933567
Period of Report: 2023-08-08

Reporting Person: MASIMO CORP (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$		Common Stock (531548.0)		Direct
Pre-Funded Warrant, Series A Preferred Stock (Right to Buy)	$0.0001		Series A Preferred Stock (144890.0)		Direct

Footnotes

F1: Each one share of Series A Preferred Stock is convertible at any time, at the holder's election, into two shares of the Issuer's Common Stock and will convert automatically upon the Issuer's consummation of an initial public offering. The Series A Preferred Stock has no expiration date.

F2: The Prefunded Warrant to Purchase Series A Preferred Stock (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant shall become exercisable for such number of shares of the Issuer's Common Stock into which the shares of Series A Preferred Stock issuable upon exercise thereof would have been converted had such shares of Series A Preferred Stock been outstanding on the date of such conversion, and the exercise prices shall equal the exercise price in effect as of immediately prior to such conversion divided by the number of shares of the Issuer's Common Stock into which one share of Series A Preferred Stock would have been converted.